Download Medical Notes on Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations

Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations Medical Notes

About This Presentation

Description:This report titled, “Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations” is by the IQVIA Institute and is an analysis of the orphan drug market. The report explores this topic of orphan drugs’ orphan and non-orphan indication approvals and their associated patent and market exclusivities. The report also examines orphan drug pricing relative to patient numbers, how those prices change over time, and – in a first-of-its-kind comprehensive analysis – compares current disease epidemiology to the number of treated patients to demonstrate the challenges in bringing orphan drugs to patients even after they are approved.

Tags:Healthcare, Orphan Drugs, United States, market, pricing, disease epidemiology

Published on: Jul 20, 2020 | Views : 1218 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

How to Win Patients with a Consumer-Grade Contact Center Experience

About : I am a passionate medical marketing professional with hands on experience in healthcare digital marketing.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : India
Website :

How to Win Patients with a Consumer-Grade Contact Center Experience

Understanding Neuromuscular Disease Care Current State and Future Prospects

2019 R&D Achievements New product launches, clinical trial activity, and investments

The Impact of the COVID-19 Pandemic on Global Pharmaceutical Growth

Life after cancer

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Pharma 2020 Taxing times ahead

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 5

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

Pharma 2020 Virtual R and D a paper on the future of the pharmaceutical industry

HEALTH A TO Z